SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-015464
Filing Date
2020-07-21
Accepted
2020-07-21 09:00:05
Documents
6
Period of Report
2020-07-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20200720_8k.htm 8-K 31428
2 EXHIBIT 4.1 ex_194651.htm EX-4.1 103591
3 EXHIBIT 10.1 ex_194652.htm EX-10.1 55510
4 EXHIBIT 10.2 ex_194653.htm EX-10.2 47752
5 EXHIBIT 10.3 ex_194654.htm EX-10.3 33034
6 logo.jpg GRAPHIC 9265
  Complete submission text file 0001437749-20-015464.txt   285499
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 201037764
SIC: 2834 Pharmaceutical Preparations